CRANFORD, N.J. , Dec. 27, 2024 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology" or the "Company") (Nasdaq: CTOR), a specialty biopharmaceutical company focused on the development and commercialization of novel targeted oncology therapies, today reported business and financial results for the fiscal full year ended September 30, 2024 . Fiscal Full Year 2024 Business Highlights and Subsequent Developments Financial Highlights "Reflecting on 2024, Citius Oncology has achieved pivotal milestones that underscore our commitment to advancing cancer therapeutics," stated Leonard Mazur , Chairman and CEO of Citius Oncology. "The FDA's approval of LYMPHIR for the treatment of cutaneous T-cell lymphoma marks a significant advancement in providing new options for patients battling this challenging disease. It is the only targeted systemic therapy approved for CTCL patients since 2018 and the only therapy with a mechanism of action that targets the IL-2 receptor. Additionally, the successful merger forming Citius Oncology, now trading on Nasdaq under the ticker CTOR, strengthens our position in the oncology sector. We expect it to facilitate greater access to capital to fund LYMPHIR's launch and the Company's future growth. With a Phase I investigator-initiated clinical trial combining LYMPHIR with pembrolizumab demonstrating promising preliminary results, indicating potential for enhanced treatment efficacy in recurrent solid tumors, and preliminary results expected from a second investigator trial with CAR-T therapies in 2025, we remain excited about the potential of LYMPHIR as a combination immunotherapy." "These accomplishments reflect the dedication of our team and the trust of our investors. As we look ahead, we remain steadfast in our mission to develop innovative therapies that improve the lives of cancer patients worldwide," added Mazur. FULL YEAR 2024 FINANCIAL RESULTS: Research and Development (R&D) Expenses R&D expenses were $4.9 million for the full year ended September 30, 2024 , compared to $4.2 million for the full year ended September 30, 2023 . The increase reflects development activities completed for the resubmission of the Biologics License Application of LYMPHIR in January 2024 , which were associated with the complete response letter remediation. General and Administrative (G&A) Expenses G&A expenses were $8.1 million for the full year ended September 30, 2024 , compared to $5.9 million for the full year ended September 30, 2023 . The increase was primarily due to costs associated with pre-commercial and commercial launch activities of LYMPHIR including market research, marketing, distribution and drug product reimbursement from health plans and payers. Stock-based Compensation Expense For the full year ended September 30, 2024 , stock-based compensation expense was $7.5 million as compared to $2.0 million for the prior year. The primary reason for the $5.5 million increase was due to the amounts being realized over 12 months in the year ended September 30, 2024 , as compared to three months post-plan adoption in the year ended September 30, 2023 . Net loss Net loss was $21.1 million , or ($0.31) per share for the year ended September 30, 2024 , compared to a net loss of $12.7 million , or ($0.19) per share for the year ended September 30, 2023 . The $8.5 million increase in net loss was primarily due to the increase in our operating expenses. About Citius Oncology, Inc. Citius Oncology specialty is a biopharmaceutical company focused on developing and commercializing novel targeted oncology therapies. In August 2024 , its primary asset, LYMPHIR, was approved by the FDA for the treatment of adults with relapsed or refractory CTCL who had had at least one prior systemic therapy. Management estimates the initial market for LYMPHIR currently exceeds $400 million , is growing, and is underserved by existing therapies. Robust intellectual property protections that span orphan drug designation, complex technology, trade secrets and pending patents for immuno-oncology use as a combination therapy with checkpoint inhibitors would further support Citius Oncology's competitive positioning. Citius Oncology is a publicly traded subsidiary of Citius Pharmaceuticals. For more information, please visit www.citiusonc.com Forward-Looking Statements This press release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such statements are made based on our expectations and beliefs concerning future events impacting Citius Oncology. You can identify these statements by the fact that they use words such as "will," "anticipate," "estimate," "expect," "plan," "should," and "may" and other words and terms of similar meaning or use of future dates. Forward-looking statements are based on management's current expectations and are subject to risks and uncertainties that could negatively affect our business, operating results, financial condition and stock price. Factors that could cause actual results to differ materially from those currently anticipated, and, unless noted otherwise, that apply to Citius Oncology are: our ability to raise additional money to fund our operations for at least the next 12 months as a going concern; our ability to commercialize LYMPHIR and any of our other product candidates that may be approved by the FDA; the estimated markets for our product candidates and the acceptance thereof by any market; the ability of our product candidates to impact the quality of life of our target patient populations; our dependence on third-party suppliers; our ability to procure cGMP commercial-scale supply; risks related to research using our assets but conducted by third parties; our ability to obtain, perform under and maintain financing and strategic agreements and relationships; uncertainties relating to preclinical and clinical testing; market and other conditions; risks related to our growth strategy; patent and intellectual property matters; our ability to identify, acquire, close and integrate product candidates and companies successfully and on a timely basis; government regulation; competition; as well as other risks described in our Securities and Exchange Commission ("SEC") filings. These risks have been and may be further impacted by any future public health risks. Accordingly, these forward-looking statements do not constitute guarantees of future performance, and you are cautioned not to place undue reliance on these forward-looking statements. Risks regarding our business are described in detail in our SEC filings which are available on the SEC's website at www.sec.gov , including in Citius Oncology's Annual Report on Form 10-K for the year ended September 30, 2024 , filed with the SEC on December 27, 2024 , as updated by our subsequent filings with the SEC. These forward-looking statements speak only as of the date hereof, and we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in our expectations or any changes in events, conditions or circumstances on which any such statement is based, except as required by law. Investor Contact: Ilanit Allen ir@citiuspharma.com 908-967-6677 x113 Media Contact: STiR-communications Greg Salsburg Greg@STiR-communications.com -- Financial Tables Follow – CITIUS ONCOLOGY, INC. CONSOLIDATED BALANCE SHEETS SEPTEMBER 30, 2024 AND 2023 2024 2023 Current Assets: Cash and cash equivalents $ 112 $ — Inventory 8,268,766 — Prepaid expenses 2,700,000 7,734,895 Total Current Assets 10,968,878 7,734,895 Other Assets: In-process research and development 73,400,000 40,000,000 Total Other Assets 73,400,000 40,000,000 Total Assets $ 84,368,878 $ 47,734,895 LIABILITIES AND STOCKHOLDERS' EQUITY Current Liabilities: Accounts payable $ 3,711,622 $ 1,289,045 License payable 28,400,000 — Accrued expenses — 259,071 Due to related party 588,806 19,499,119 Total Current Liabilities 32,700,429 21,047,235 Deferred tax liability 1,728,000 1,152,000 Note payable to related party 3,800,111 — Total Liabilities 38,228,540 22,199,235 Stockholders' Equity: Preferred stock - $0.0001 par value; 10,000,000 shares authorized: no shares issued and outstanding — — Common stock - $0.0001 par value; 100,000,000; 71,552,402 and 67,500,000 shares issued and outstanding at September 30, 2024 and 2023, respectively 7,155 6,750 Additional paid-in capital 85,411,771 43,658,750 Accumulated deficit (39,278,587) (18,129,840) Total Stockholders' Equity 46,140,339 25,535,660 Total Liabilities and Stockholders' Equity $ 84,368,878 $ 47,734,895 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Revenues $ — $ — Operating Expenses: Research and development 4,925,001 4,240,451 General and administrative 8,148,929 5,915,290 Stock-based compensation – general and administrative 7,498,817 1,965,500 Total Operating Expenses 20,572,747 12,121,241 Loss before Income Taxes (20,572,747) (12,121,241) Income tax expense 576,000 576,000 Net Loss $ (21,148,747) $ (12,697,241) Net Loss Per Share – Basic and Diluted $ (0.31) $ (0.19) Weighted Average Common Shares Outstanding – Basic and Diluted 68,053,607 67,500,000 CITIUS ONCOLOGY, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED SEPTEMBER 30, 2024 AND 2023 2024 2023 Cash Flows From Operating Activities: Net loss $ (21,148,747) $ (12,697,241) Adjustments to reconcile net loss to net cash provided by operating activities: Stock-based compensation expense 7,498,817 1,965,500 Deferred income tax expense 576,000 576,000 Changes in operating assets and liabilities: Inventory (2,133,871) - Prepaid expenses (1,100,000) (5,044,713) Accounts payable 2,422,577 1,196,734 Accrued expenses (259,071) (801,754) Due to related party 14,270,648 14,805,474 Net Cash Provided By Operating Activities 126,353 - Cash Flows From Investing Activities: License payment (5,000,000) - Net Cash Used In Investing Activities (5,000,000) - Cash Flows From Financing Activities: Cash contributed by parent 3,827,944 - Merger, net (2,754,296) - Proceeds from issuance of note payable to related party 3,800,111 - Net Cash Provided By Financing Activities 4,873,759 - Net Change in Cash and Cash Equivalents 112 - Cash and Cash Equivalents – Beginning of Year - - Cash and Cash Equivalents – End of Year $ 112 $ - Supplemental Disclosures of Cash Flow Information and Non-cash Activities: IPR&D Milestones included in License Payable $ 28,400,000 $

Pedro escaped punishment after swinging an arm at Bees substitute substitute Yehor Yarmoliuk without making contact. VAR reviewed the second-half incident but deemed there was no violent conduct. Frank and Brighton head coach Fabian Hurzeler disagreed about the decision. “As I understand the rules, you can’t swing your arm to try to hit someone,” said Frank. “If you hit them or not, it’s a red, that’s the way I understand the rules.” Frank spoke to the match officials, including referee Andy Madley, about the flashpoint at full-time. “They haven’t seen the situation yet, not on TV afterwards,” said Frank. “To be fair to him, I think the angle can be tricky so that’s why you’ve got VAR.” Asked about Frank’s assessment, Hurzeler replied: “Interesting opinion. I see it completely different. “For me, it’s not a red card. He tried to get free from a person.” Brighton were booed off after their winless run was stretched to six top-flight games. Albion dominated for large periods and hit the woodwork inside four minutes through Julio Enciso. Bees goalkeeper Mark Flekken made some important saves before being forced off injured in the 36th minute, albeit his replacement Hakon Valdimarsson was rarely tested on his Premier League debut. The Seagulls remain 10th ahead of Monday’s trip to Aston Villa, with Brentford a position and two points below moving towards their New Year’s Day showdown with Arsenal. Hurzeler thought the jeers at full-time were unfair. “The team doesn’t deserve that because in all the games we had in the last weeks they were all good, they were all intense, they were all where we thought we deserved more” said the German, whose team have lost to Fulham and Crystal Palace and drawn with Southampton, Leicester and West Ham in recent matches. “We try to work hard to satisfy our supporters, we try to give them what they deserve, we try to make them proud. “But the Premier League is tough. We know there will be (tough) periods we have to go through, especially with this young squad. “We try to stick together, find the positive and keep on going.” Brentford, who remain without a top-flight away win this term, had an early Yoane Wissa finish ruled out for offside following VAR intervention but barely threatened, despite an improved second-half showing. Frank, who is awaiting news on Flekken and defender Ben Mee, who also left the field injured, said: “I thought it was a fair point. “Brighton were better in the first half, no big, clearcut chances, and I thought we were better second half. “Overall, I’m happy with the performance, especially the way we defended. “We haven’t had too many clean sheets this season, so in that context I thought it was very impressive against a good Brighton team. “We know we have a lot of players out – we get two more injuries during the game. “The way the players showed their mentality and character and dug in was hugely impressive.”The standard Lorem Ipsum passage, used since the 1500s "Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum." Section 1.10.32 of "de Finibus Bonorum et Malorum", written by Cicero in 45 BC "Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam, eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo. Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione voluptatem sequi nesciunt. Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt ut labore et dolore magnam aliquam quaerat voluptatem. Ut enim ad minima veniam, quis nostrum exercitationem ullam corporis suscipit laboriosam, nisi ut aliquid ex ea commodi consequatur? Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum fugiat quo voluptas nulla pariatur?" To keep reading, please log in to your account, create a free account, or simply fill out the form below.

Yet another billionaire is clambering to get into President-elect Donald Trump’s hyper-rich inner circle, the MAGA chief has claimed. Trump, who will take the hot seat on Jan. 20, 2025, has seen his popularity surge among Silicon Valley types after he was endorsed by the world’s richest man, Elon Musk . The number two, Amazon founder Jeff Bezos , soon made a beeline for the big man too, after he was spotted dining with Musk and Trump at Mar-a-Lago earlier this month. Now Bill Gates wants a slice, according to Trump. Writing on Truth Social, Trump said the former CEO of Microsoft— whom Forbes says is the 16th richest in the world— personally asked for an audience with him. In a somewhat incoherent post, he said: “Where are you? When are you coming to the ‘Center of the Universe,’ Mar-a-Lago. Bill Gates asked to come, tonight. We miss you and x! New Year’s Eve is going to be AMAZING!!! DJT.” The murder of health insurance CEO Brian Thompson is being blamed not just on the gunman–but on the industry the dead man worked for, a new poll has found. UnitedHealthcare CEO Thompson was gunned down from behind on a Manhattan street just before dawn on December 4, prompting a nationwide manhunt which ended five days later with the arrest of the suspected killer , 26-year-old Ivy League graduate Luigi Mangione . Now research by NORC at the University of Chicago published Friday shows that while 78 per cent of people said that the alleged killer, had a great deal or a moderate amount of responsibility for the death, almost as many blamed health insurance companies' denial of coverage for the death. And almost as many, 67 per cent, said profits by the insurers were to blame. A majority of people, 53 per cent, blamed “wealth or income inequality in general”–although it was Mangione who was the scion of a millionaire family , while Thompson was from rural Iowa and had been the first in his family to go to college. One in ten said that Thompson’s killer bore no responsibility at all–an issue which is likely to dog jury selection when Mangione goes on trial in Manhattan for the alleged murder. He is charged by both federal and state authorities with murder and in the federal case is eligible for the death penalty . Mangione has pleaded not guilty. After all the chaos of the holiday season, you and your loved one deserve a little one-on-one time. For 2025, make the resolution to create unforgettable date nights with The Fantasy Box . The subscription box comes with everything you need to spice up your love life, like step-by-step scenarios for role-playing, lingerie, accessories, lube, and props. Each box has a unique theme and there are over 30 different themed fantasies to pick. The Ride ‘Em Cowgirl scenario brings you to the wild west. She is a flirty cowgirl in sexy denim shorts and cow print pasties, while he is a charming bartender with a paddle. Perhaps you’re intrigued by the idea of exploring a more dominant and submissive dynamic. In the D is for Discipline box , she is the Mistress with drip candles and he is her toy in a satin blindfold and bondage collar. The Fantasy Box has created a quick quiz you can take to uncover you and your partner’s fantasies. After taking the quiz, you’ll be recommended three boxes. From there, you can buy any box you want directly. Don’t forget to use the code NEWYEAR at checkout to save $50 on your order. If you and your partner love it, try subscribing monthly or bi-monthly for only $99 the first month. Monthly subscriptions renew at $129 per box; bi-monthly at $139 per box. You’ll receive a new themed box, enjoy free shipping, and get up to 20% off at The Fantasy Box’s shop. Free Shipping Free Shipping If you buy something from this post, we may earn a small commission. Tom Cruise ’s first movie project after wrapping up the Mission: Impossible franchise next year with The Final Reckoning has been revealed. And it could land him back in the Oscar conversation. Warner Bros. announced Friday that Cruise will star in an untitled film from two-time Academy Award-winning director Alejandro G. Iñárritu ( Birdman , The Revenant ), set to be released on Oct. 2, 2026. The logline reads: “The most powerful man in the world embarks on a frantic mission to prove he is humanity’s savior before the disaster he’s unleashed destroys everything.” Sandra Hüller, John Goodman, Michael Stuhlbarg, Jesse Plemons, Sophie Wilde, and Riz Ahmed are among the other actors in the cast. The project is Iñárritu‘s first English-language film since 2015’s The Revenant , which won Leonardo DiCaprio his first Oscar for Best Actor. Cruise has been nominated for three acting Oscars over the course of his long career—for Born on the Fourth of July , Jerry Maguire , and Magnolia —but has never received a trophy at the ceremony. Entire stalls were engulfed by flames at the Bryant Park holiday market in Manhattan on Friday morning, videos show. A cause for the blaze is yet to be determined, but a spokesperson for FDNY told Gothamist it’s under investigation. The fire broke out around 9:30 a.m. and nobody was injured, the spokesperson said, adding that the fire was between “six feet wide by 40 feet long” at its peak. Clips of the flames quickly went viral on social media and the market has been closed indefinitely. New York City Emergency Management advised people to avoid the area and warned there will be traffic delays while a probe is completed. It’s the second time this season a holiday market has gone up in flames in the city, coming a week-and-a-half after a fire ignited a swath of Herald Square’s festive shopping corridor. Eighteen shops—and their merchandise, ranging from shirts to glass ornaments—were reportedly razed by that blaze. Bryant Park Christmas Village is on fire 🔥 #whatisnewyork pic.twitter.com/031iZ2D6He Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Boxing Week sales are still in full swing, folks! As an avid J.Crew fan , I can honestly say that the brand’s discount-laden factory store (the brand’s online outlet) is a great way to get high-quality wardrobe staples without the big price tag. J.Crew Factory always offers discounts up to 40 percent off J.Crew, but for a limited time, you can unlock even more savings from already discounted items. Right now, J.Crew Factory is offering 70 percent off clearance items with the code SALE70 at checkout. Now’s the time to invest in evergreen staples like jeans and office-friendly blazers while they’re half off, or grab a few outwear essentials to round out your cold-weather lineup. The sale also includes tons of denim for just $50, pure cotton crewneck T-shirts for $20, and even new arrivals like NYE frocks and cashmere items. And the sale is not just for women; the gents’ and kids’ sections are equally full of additional savings. Kevin O’Leary , of Shark Tank fame, says half of Canada is “interested” in merging with the U.S.—a longshot arrangement that topped Donald Trump ’s wishlist this Christmas. “Canadians over the holidays—the last two days—have been talking about this,” O’Leary told Fox Business. “They want to hear more.” The 70-year-old Montreal native said he’s headed to Mar-a-Lago to start a conversation that, at the least, may lead to his homeland and the U.S. striking a partnership agreement akin to the European Union. “So secure [the northern territories], give a common currency, figure out taxes across the board, get everything trading both ways, create a new, almost EU-like passport—I like this idea and at least half of Canadians are interested,” he said. O’Leary acknowledged there’d be “a lot of issues” with a merger, but suggested now’s the time to get a deal done with Trump returning to office as Prime Minister Justin Trudeau’s power is waning. O’Leary may not be the best barometer for what the average Canadian thinks, however. The businessman, worth an estimated $400 million , has ditched the great white north for sunny Miami Beach . He was also soundly rejected by voters when he ran for the leadership of the Canadian Conservative Party in 2017 and won just one percent of the vote. Elon Musk has further stoked the flames of the MAGA H1-B civil war after he agreed with a post that called Americans too “retarded” to exclusively fill the U.S. tech workforce. The eye-popping endorsement came after a pro-Musk account on X summed up the right-wing divide on visas to skilled workers as such: “So basically the right split into two factions, tech right and right right, and the tech right is like ‘hey we need h-1b visa people to do the jobs,’ and the right right was like ‘no you need to hire Americans,’ and the tech right is like “but you guys are retarded,” and the right right is like ‘well you don’t train us,’ and the tech right is like ‘you can’t outtrain being retarded,’ and while all this was going on we learned some people *really* don’t like Indians.” Musk, a 53-year-old South African who’s recently enjoyed a spot inside the “America First” Trump’s inner circle, apparently thought that assessment was a fair one. He responded, “That pretty much sums it up. This was eye-opening.” Trump is yet to weigh in on the latest right-wing divide that pits his longtime loyalists against his new tech bro faction. That pretty much sums it up. This was eye-opening. Several aviation experts said they believe that a Russian defense system caused the Azerbaijan Airlines plane crash that killed 38 people on Christmas Day, according to the Associated Press. The flight was headed from Baku, Azerbaijan, to Grozny, Russia, but diverted course amid bad weather before crash landing near Aktau, Kazakhstan. The incident left 29 survivors, all of whom are injured, the AP reported. With investigations underway in Azerbaijan, Kazakhstan, and Russia, officials in those countries have urged against speculation about the crash’s cause. Russia’s aviation authority has suggested, nevertheless, that a bird strike could have played a role. But aviation experts seem to disagree. Mark Zee, founder of the aviation safety organization OPSGroup, told the AP that based on images of the plane, he is “90-99%” sure it was struck by a missile. Independent Russian military expert Yan Matveyev agreed that the plane’s tail appeared to have been struck by shrapnel from a missile like the ones used by Russia’s defense system. Meanwhile, the UK aviation security firm Osprey Solutions reportedly cautioned its clients that “Azerbaijan Airlines flight was likely shot down by a Russian military air-defense system.” The man suspected of lighting a woman on fire in a Brooklyn subway car faces life without parole after he was charged with murder . Sebastian Zapeta-Calil, 33, has been indicted on charges of murder in the first and second degree and arson, according to Brooklyn District Attorney Eric Gonzalez. The horrific scene unfolded on an early morning F train stopped at the Coney Island-Stillwell Ave. stop in south Brooklyn on Dec. 22. Zapeta is accused of igniting the woman’s clothes and “fanning the flames” with a shirt. “These are significant counts. Murder in the first degree carries the possibility of life without parole. It’s the most serious statute in New York state law and my office is very confident about the evidence in the case and to hold Zapeta accountable for his dastardly deeds,” Gonzalez said. Zapeta, an undocumented immigrant from Guatemala, is scheduled to be arraigned Jan. 7. Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. If you’re looking to revamp your at-home fitness lineup ahead of 2025 and don’t have hours to commit to exercising each day, allow us to introduce you to the CAROL Bike . The science-backed and AI-powered fitness bike is engineered to give you maximum results in the shortest time possible—and by the shortest time, we mean as little as five minutes. In fact, according to the brand, the CAROL bike is “proven to deliver double the health and fitness benefits in 90 percent less time compared to regular cardio.” Free Returns | Free Shipping Not only is it a huge time-saver, but the CAROL Bike is also designed to be personalized to the rider’s individual fitness levels, goals, and preferences, making the workouts easy to follow, time-efficient, and super effective. CAROL’s AI and Reduced Exertion HIIT (REHIT) technology optimizes the workout to your ability and fitness level, so every second matters. The personalized, optimal resistance levels are automatically adjusted as you work out—at exactly the right time—making the most efficient workouts easy to follow. “ CAROL Bike is designed to maximize training efficiency, with the shortest, most effective workouts, backed by science. And new rider-inspired features that give riders more flexibility to exercise their way,” says Ulrich Dempfle, CEO & Co-Founder at CAROL. You can try the CAROL Bike for yourself risk-free for 100 days, and the brand offers free shipping (7-10 business days) in the U.S. Chaos descended in South Korea ‘s parliament again after the man tasked with succeeding the country’s recently impeached president was also given the boot. Acting president, formerly the Prime Minister, Han Duck-soo, was brought in two weeks after parliament voted to impeach President Yoon Suk Yeol after his failed bid to impose martial law on the country. But Han was accused Friday of dragging his heels in pushing through the Yoon impeachment after he refused to appoint three judges to fill vacancies in the Constitutional Court that would vote on Yoon’s future. As a result, 192 lawmakers voted for Han’s impeachment. However, it was the decision to lower the threshold of required votes from 200 for Yoon’s removal to just 151 that caused lawmakers from the ruling People Power Party to swarm National Assembly speaker Woo Won-shik. “Invalid!” and “Abuse of power!” were among the angry chants. The majority of the parliament in South Korea is from the opposition Democratic Party. Yoon is from the right-wing People Power Party, while Han is an independent. Deputy Prime Minister Choi Sang-mok has taken the reigns... for now. South Korea's parliament voted to impeach acting president Han Duck-soo, prompting chaos as ruling party lawmakers protested the speaker’s decision to allow only 150 votes to pass the bill against Han, which meant no ruling party lawmakers’ votes were needed. pic.twitter.com/BgX9D8vrwh The 92-year-old mother of a murder victim whose death spurred the conviction—later overturned—of a member of the Kennedy family, died Tuesday of complications from the flu, her son said. Dorthy Moxley fought nearly 50 years for justice after her teenage daughter, Martha, was found dead across the street from the family home of Michael Skakel, a cousin of Robert F. Kennedy Jr. Skakel was convicted of Martha’s murder in 2002 and freed in 2013 after a judge said he hadn’t received adequate representation. The Connecticut Supreme Court reinstated the conviction in 2016, only to order him freed two years later. A second trial never occurred, in part because some witnesses had died. “It was just incredible how much support we got from people that we knew and people that we didn’t know,” Moxley’s son, John, told the Associated Press . “My mother was always grateful and chose to focus on the communal spirit, if you will, rather than the law. My mother always said she believed in angels and the angels really came out to support her, to support us.” John added: “She was able to take that spirit of support and knowing how important it was to share that with others. And that gave her a lot of joy, knowing that she could help somebody else.”

NEW YORK (AP) — A number of President-elect Donald Trump 's most prominent Cabinet picks and appointees have been targeted by bomb threats and “swatting attacks," Trump's transition team said Wednesday. The FBI said it was investigating. “Last night and this morning, several of President Trump’s Cabinet nominees and Administration appointees were targeted in violent, unAmerican threats to their lives and those who live with them," Trump transition spokesperson Karoline Leavitt said in a statement. She said the attacks ranged from bomb threats to swatting, in which attackers initiate an emergency law enforcement response against a target victim under false pretenses. The tactic has become a popular one in recent years. “In response, law enforcement and other authorities acted quickly to ensure the safety of those who were targeted. President Trump and the entire Transition team are grateful for their swift action,” Leavitt said. Among those targeted were New York Rep. Elise Stefanik, Trump’s pick to serve as the next ambassador to the United Nations , Matt Gaetz, Trump’s initial pick to serve as attorney general , and former New York congressman Lee Zeldin, who has been tapped to lead the Environmental Protection Agency. Susie Wiles, Trump's incoming chief of staff, and Pam Bondi, the former Florida Attorney General whom Trump has chosen as Gaetz's replacement, were also targeted, according to a law enforcement official who spoke on condition of anonymity amid the ongoing investigation. Wiles and Bondi did not immediately respond to requests for comment. The FBI said in a statement that it was “aware of numerous bomb threats and swatting incidents targeting incoming administration nominees and appointees" and was "working with our law enforcement partners. We take all potential threats seriously, and as always, encourage members of the public to immediately report anything they consider suspicious to law enforcement.” Stefanik's office said that, on Wednesday morning, she, her husband, and their 3-year-old son were driving home from Washington for Thanksgiving when they were informed of a bomb threat to their residence in Saratoga County. "New York State, County law enforcement, and U.S. Capitol Police responded immediately with the highest levels of professionalism," her office said in a statement. “We are incredibly appreciative of the extraordinary dedication of law enforcement officers who keep our communities safe 24/7." The New York State Police said a team was dispatched to sweep Stefanik’s home on Wednesday morning in response to the bomb threat but did not locate any explosive devices. A spokesman for the agency directed further questions to the FBI. Zeldin said in a social media post that he and his family had been threatened. “A pipe bomb threat targeting me and my family at our home today was sent in with a pro-Palestinian themed message,” he wrote on X . “My family and I were not home at the time and are safe. We are working with law enforcement to learn more as this situation develops.” Police in Suffolk County, Long Island said emergency officers responded to a bomb threat Wednesday morning at an address listed in public records as Zeldin’s home and were checking the property. In Florida, meanwhile, the Okaloosa County sheriff’s office said in an advisory posted on Facebook that it “received notification of a bomb threat referencing former Congressman Matt Gaetz’s supposed mailbox at a home in the Niceville area around 9 a.m. this morning.” While a family member resides at the address, they said "former Congressman Gaetz is NOT a resident. The mailbox however was cleared and no devices were located. The immediate area was also searched with negative results.” Gaetz was Trump’s initial pick to serve as attorney general, but he withdrew from consideration amid allegations that he paid women for sex and slept with underage women. Gaetz has vehemently denied any wrongdoing and said last year that a Justice Department investigation into sex trafficking allegations involving underage girls had ended with no federal charges against him. The threats follow a political campaign marked by disturbing and unprecedented violence. In July, a gunman opened fire at a Trump rally in Butler, Pennsylvania, grazing the then-candidate in the ear with a bullet and killing one of his supporters. The U.S. Secret Service later thwarted a subsequent assassination attempt at Trump's West Palm Beach, Florida, golf course when an agent spotted the barrel of a gun poking through a perimeter fence while Trump was golfing. Public figures across the political spectrum have been targeted in recent years by hoax bomb threats and false reports of shootings at their homes. The judges overseeing the civil fraud case against Trump in New York and the criminal election interference case against him in Washington, D.C. were both targeted earlier this year. Justice Department special counsel Jack Smith, who recently abandoned the two criminal cases he brought against Trump, was also the subject of a fake emergency call on Christmas Day last year. Earlier this year, schools, government buildings and the homes of city officials in Springfield, Ohio received a string of hoax bomb threats after Trump falsely accused members of Springfield’s Haitian community of abducting and eating cats and dogs. And in 2022, a slew of historically Black colleges and universities nationwide were targeted with dozens of bomb threats with the vast majority arriving during the celebration of Black History Month. The U.S. Capitol Police said in a statement Wednesday that, “Anytime a Member of Congress is the victim of a 'swatting' incident, we work closely with our local and federal law enforcement partners. To protect ongoing investigations and to minimize the risk of copy-cats, we cannot provide more details at this time.” Republican House Speaker Mike Johnson called the threats “dangerous and unhinged.” “This year, there was not just one but TWO assassination attempts on President Trump. Now some of his Cabinet nominees and their families are facing bomb threats,” he wrote on X . “It is not who we are in America.” ___ Associated Press writers Alanna Durkin Richer, Colleen Long and Eric Tucker in Washington and Anthony Izaguirre in Albany, New York contributed to this report.FG targets STEM, vocational education in new strategy

Zion Williamson's Weight Called Into Question After Viral Video Surfaces

The Ahmadu Bello University Teaching Hospital (ABUTH) Zaria is set to begin kidney transplant surgeries in 2025, aiming to provide relief to patients with kidney failure and reduce medical tourism. Prof. Ahmed Umdagas, the hospital’s Chief Medical Director, revealed this in an interview with the News Agency of Nigeria (NAN) on Sunday in Zaria. He announced that the Urology Centre of Excellence, which will deliver advanced urology services, is expected to be operational by the first quarter of 2025. Related Stories Nigerians with kidney ailments face high dialysis costs as transplant exceeds N14 million US Surgeons perform the first pig to human kidney transplant “By the first quarter of 2025, ABUTH would commence kidney transplant. What was just holding us was a few infrastructure,” Umdagas said. He added that most of the required machines and equipment are already in place, and personnel have been adequately trained to deliver the services. Umdagas stated that the Urology Centre of Excellence at ABUTH would be ready by the first quarter of 2025 to deliver high-quality urology services. “By the first quarter of 2025, ABUTH will commence kidney transplants. What has been holding us back is a few infrastructure upgrades,” he said. He added, “Besides that, most of the machines and equipment required for kidney transplants are available, and our personnel have been adequately trained to provide the services.” Umdagas also revealed plans for an Amenity Wing, designed to accommodate patients from all classes. According to him, the Amenity Wing will feature a single-bedroom and a room-and-parlor option for affluent patients, emphasizing that ABUTH is committed to offering world-class services. “The Amenity Wing will have a dedicated line and a website,” Umdagas explained. “The website will showcase the profiles of doctors in the hospital. When a patient wants to see a specific professor or specialist, they will simply need to use the dedicated line or the website to book an appointment seamlessly.” Similarly, the Chief Medical Director (CMD) also disclosed that a contract has been awarded for the procurement of linear machines to enhance cancer care at the facility. Speaking on additional efforts to curb medical tourism, the CMD highlighted that ABUTH boasts a fully functional 128 Slice CT Scan machine. He explained, “If you undergo an investigation abroad requiring the 128 Slice CT Scan, it costs no less than $200, which is over N300,000. Meanwhile, ABUTH charges just N30,000 for the same service.” The CMD noted that many patients now come to ABUTH for scans, take the results abroad, and continue their treatments there. “ We also have 1.5 Tesla MRI and 0.2 Tesla MRI machines, which are advanced imaging technologies . These machines are fully functional, and the cost for such services at ABUTH is significantly lower than what is charged elsewhere in Nigeria.” , He said. He added, “We also perform lithotripsy at ABUTH, which involves breaking stones using lasers instead of surgery.” Umdagas further shared that the hospital had celebrated over five successful IVF cases in collaboration with its partners. He revealed plans to establish a dedicated unit for IVF services in future budgets, ensuring all necessary equipment is housed in one facility.Colts coach Shane Steichen feeling heat after playoff eliminationNone

Trump selects longtime adviser Keith Kellogg as special envoy for Ukraine and Russia